Dr. Martens (LON:DOCS) Stock Price Up 18.8% - Still a Buy?

Dr. Martens plc (LON:DOCS - Get Free Report)'s share price was up 18.8% during trading on Thursday . The stock traded as high as GBX 74.30 ($1.01) and last traded at GBX 71.25 ($0.97). Approximately 6,397,914 shares were traded during trading, an increase of 186% from the average daily volume of 2,235,389 shares. The stock had previously closed at GBX 59.95 ($0.81).

Analyst Ratings Changes

Separately, Royal Bank of Canada reduced their price target on Dr. Martens from GBX 7,000 ($95.06) to GBX 6,000 ($81.48) and set a "sector perform" rating on the stock in a research report on Monday, May 19th.

Dr. Martens Stock Up 25.8%

The firm has a 50-day moving average of GBX 54.24 and a 200 day moving average of GBX 62.52. The stock has a market capitalization of £731.96 million, a price-to-earnings ratio of 10.69, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11. The company has a current ratio of 2.85, a quick ratio of 1.13 and a debt-to-equity ratio of 127.27.

Dr. Martens (LON:DOCS - Get Free Report) last posted its quarterly earnings data on Thursday, June 5th. The company reported GBX 2.40 ($0.03) earnings per share (EPS) for the quarter. Dr. Martens had a return on equity of 18.91% and a net margin of 7.89%. On average, sell-side analysts anticipate that Dr. Martens plc will post 2.5809394 earnings per share for the current year.

Dr. Martens Cuts Dividend

The company also recently declared a dividend, which was paid on Tuesday, April 8th. Stockholders of record on Thursday, March 6th were issued a GBX 0.85 ($0.01) dividend. The ex-dividend date was Thursday, March 6th. This represents a dividend yield of 1.47%. Dr. Martens's dividend payout ratio (DPR) is 42.53%.

Insider Activity

In related news, insider Giles Wilson acquired 32,640 shares of Dr. Martens stock in a transaction that occurred on Tuesday, March 25th. The stock was acquired at an average price of GBX 54 ($0.73) per share, for a total transaction of £17,625.60 ($23,934.82). In the last ninety days, insiders bought 33,206 shares of company stock worth $1,792,771. 4.36% of the stock is currently owned by insiders.

Dr. Martens Company Profile

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of empowerment and their own individual attitude. The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and is a constituent of the FTSE 250 index.